Inhibition of liver fibrosis by oxysterol drug candidates in a mouse model of nash
Ended Project Grant Awarded Last action
- Award ID
- R43DK125139
- Recipient
-
Max Biopharma, Inc. UEI NZ8XY5DKRAD3
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $223,696
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $223,696 |
Quick answers
Who received award R43DK125139?
R43DK125139 was awarded to Max Biopharma, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on August 21, 2020.
How much is award R43DK125139 worth?
$223,696 has been obligated on R43DK125139.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award